Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00765752 · ClinicalTrials.gov registry record
Cortical GABA Concentrations in Insomnia
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 23
- Enrollment target
NCT00765752 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 23 participants.
The verdict
NCT00765752 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
Disturbances in the amino acid neurotransmitter (AANt), gamma-amino butyric acid (GABA) function are hypothesized to contribute to the neurobiology of Major Depressive Disorder (MDD) and insomnia. The principal objective of this project is to use magnetic resonance spectroscopy (MRS) to provide the first in vivo characterization of cortical GABA levels in individuals with primary insomnia, and to determine whether subjects with MDD, achieving a partial response with selective serotonin reuptake inhibitor treatment but still experiencing significant residual symptoms including insomnia, have altered levels of this neurotransmitter. The investigators are also exploring the correlation between cortical AANt levels and abnormalities in sleep parameters in primary insomnia and as a residual symptom of major depression.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00765752
The ClinicalTrials.gov registry entry for NCT00765752 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00765752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00765752 about?
NCT00765752 is a clinical study titled "Cortical GABA Concentrations in Insomnia". Disturbances in the amino acid neurotransmitter (AANt), gamma-amino butyric acid (GABA) function are hypothesized to contribute to the neurobiology of Major Depressive Disorder (MDD) and insomnia. The principal objective of this project is to use magnetic resonance spectroscopy (MRS) to provide the ...
What is the current status of trial NCT00765752?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2007-11. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT00765752?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.